Sanofi India seeks shareholder approval for new managing director Deepak Arora

Sanofi India Limited is seeking shareholder approval for the appointment of Deepak Arora as a director and managing director. The appointment is for a three-year term, effective from October 27, 2025, to October 26, 2028, following recommendations from the nomination and remuneration committee and approval by the board of directors. The postal ballot will be conducted exclusively through remote e-voting.

The e-voting period for this resolution commences at 9:00 a.m. (IST) on Tuesday, November 18, 2025, and concludes at 5:00 p.m. (IST) on Wednesday, December 17, 2025. The results of the postal ballot are expected to be declared on or before Friday, December 19, 2025. Only members whose email addresses are registered with the company or depositories as of the cut-off date, Friday, November 14, 2025, are eligible to participate.

Arora's proposed remuneration includes a basic salary of INR 1,36,25,000 per annum and a flexi compensation plan of INR 1,13,34,638 per annum, along with other benefits such as provident fund, gratuity, performance bonuses (target payout of INR 68,12,500 for FY2025), and relocation support. His appointment is subject to approval from the Central Government, as he has not resided continuously in India for 12 months prior to his appointment.